Epstein-barr Virus Nk Lymphoproliferative Disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-06-19
Clinical Trial Update: Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease [Phase 4]
Phase 4 clinical trial updating a myeloablative allogeneic stem cell transplant protocol to treat Epstein-Barr virus T/NK lymphoproliferativ…